[Federal Register Volume 80, Number 16 (Monday, January 26, 2015)]
[Notices]
[Page 3979]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-01313]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Halo 
Pharmaceutical, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before March 27, 2015.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152. Request for 
hearings should be sent to: Drug Enforcement Administration, Attention: 
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:
    The Attorney General has delegated his authority under the 
Controlled Substances Act to the Administrator of the Drug Enforcement 
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all 
necessary functions with respect to the promulgation and implementation 
of 21 CFR part 1301, incident to the registration of manufacturers, 
distributors, and dispensers, of controlled substances (other than 
final orders in connection with suspension, denial, or revocation of 
registration) has been redelegated to the Deputy Assistant 
Administrator of the DEA Office of Diversion Control (``Deputy 
Assistant Administrator'') pursuant to section 7 of 28 CFR pt. 0, 
subpt. R, App.
    In accordance with 21 CFR 1301.33(a), this is notice that on July 
21, 2014, Halo Pharmaceutical, Inc., 30 North Jefferson Road, Whippany, 
New Jersey 07981, applied to be registered as a bulk manufacturer of 
the following basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Hydromorphone (9150).......................  II
------------------------------------------------------------------------

    The company plans to manufacture Hydromorphone HCl for sale to 
other manufacturers and to manufacture other controlled substances for 
distribution to its customers. Dihydromorphine is an intermediate in 
the manufacture of Hydromorphone and is not for commercial 
distribution.

    Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01313 Filed 1-23-15; 8:45 am]
BILLING CODE P